Ink jet printing composition comprising a dye containing hydrazine or hydrazide

[0001] This invention relates to dyes, to inks and to their use in ink jet printing (“IJP”). IJP is a non-impact printing technique in which droplets of ink are ejected through a fine nozzle onto a substrate without bringing the nozzle into contact with the substrate.

[0002] There are many demanding performance requirements for dyes and inks used in IJP. For example they desirably provide sharp, non-feathered images having good water-fastness, and optical density. The inks are often required to dry quickly when applied to a substrate to prevent smudging, but they should not form a crust over the tip of an ink jet nozzle because this will stop the printer from working. The inks should also be stable to storage over time without decomposing or forming a precipitate which could block the fine nozzle.

[0003] With the increasing popularity of using IJP for printing photographic images and for posters displayed outdoors a need has arisen for inks and dyes having improved light-fastness properties. Many of the inks and dyes currently available have poor light-fastness, resulting in discoloration and fading of printed images in a short space of time. The provision of inks and dyes meeting the demanding performance requirements of IJP and at the same time demonstrating improved light-fastness represents a major challenge.

[0004] According to the present invention there is provided a composition comprising

[0005] (a) a liquid medium; and

[0006] (b) a compound comprising one or more chromophoric groups and one or more hydrazine or hydrazide groups;

[0007] wherein the liquid medium comprises water and an organic solvent, an organic solvent free from water, or a low melting point solid.

[0008] Preferably the compound is red, orange, yellow, green, blue, indigo, violet or black.

[0009] Preferably the compound comprises from 1 to 8 groups selected from hydrazine and hydrazide groups, more preferably 1, 2, 3 or 4, especially 1 or 2, more especially 2 groups selected from hydrazine and hydrazide groups. The compound may contain both hydrazine and hydrazide groups.

[0010] The hydrazine and hydrazide groups preferably comprise a group of the Formula (2):

[0011] wherein:

[0012] p is 0, 1 or 2.

[0013] Groups of Formula (2) where p is zero are hydrazines. When p is 1 or 2 then the groups of Formula (2) are hydrazides. As is well known in the art, the terms hydrazine and hydrazide do not include hydrazone (e.g. ═N—NH—) or azo (—N═N—).

[0014] Preferred hydrazine and hydrazide groups of Formula (2) are of Formula (2a) or (2b) as follows:

[0015] wherein:

[0016] p is 0, 1 or 2;

[0017] Q1 and Q2 are each independently H, optionally substituted alkyl or optionally substituted aryl, or Q1 and Q2 together with the nitrogen atoms to which they are attached form an optionally substituted 5- or 6-membered ring;

[0018] Q3 together with the nitrogen atom to which it is attached forms an optionally substituted 5- or 6-membered ring; and

[0019] Q4 is H, optionally substituted alkyl or optionally substituted aryl.

[0020] Preferably p is 1 or 2, more preferably 1.

[0021] Examples of hydrazine groups of Formula (2a) include those listed later in this specification in Table 2, Examples 17, 20, 23, 25, 26, 27, 28, 29, 31, 33, 34, 35 and 37.

[0022] Examples of hydrazide groups of Formula (2a) include those listed later in this specification in Table 2, Examples 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 24, 30, 32 and 38.

[0023] Examples of hydrazine groups of Formula (2b) include those listed in Table 5, Example 134 and Table 1, Example 36.

[0024] Examples of hydrazide groups of Formula (2b) include the group listed in Table 5, Example 127.

[0025] In a preferred embodiment Q1, Q2 and Q4 are each independently H or C1-4-alkyl, more preferably H.

[0026] Preferably the compound further comprises one or two triazine groups.

[0027] Preferably at least one (more preferably all) of the hydrazine and hydrazide groups is located in the compound such that it is connected directly to a triazine ring by one covalent bond.

[0028] Preferably the compound further comprises one or more water solubilising groups.

[0029] Preferred water-solubilising groups are sulpho, carboxy and phosphate.

[0030] Preferably the compound has at least one carboxy group, more preferably 1 to 8 carboxy groups, especially 1 to 4 carboxy groups. In one embodiment the compound has at least as many carboxy groups as sulpho groups.

[0031] The compound may be in free acid form or in the form of a salt with a cation or mixture of cations. Preferred cations include alkali metals, especially lithium, sodium and potassium, and ammonium and substituted ammonium (e.g. tetramethylammonium or ethylammonium).

[0032] Preferably the compound is free from fibre reactive groups, e.g. free from halotriazine groups, because such groups are not needed in the compounds. Furthermore, halotriazine groups may hydrolyse when stored in an ink to release acid and reduce storage stability of the ink.

[0033] In preferred aspects of the present invention the composition comprises a compound which:

[0034] (i) is free from groups of Formula (1) and salts thereof;

[0035]

1
(ii) comprises a single group of Formula (1) or salt thereof; or

[0036] (iii) comprises two or more groups of Formula (1) or salts thereof:

[0037] When the compound is free from groups of Formula (1) and salts thereof the compound is preferably of Formula (3) or a salt-thereof:

[0038] wherein:

[0039] each D independently is a chromophoric group;

[0040] n is at least one;

[0041] R1 is H or a substituent; and

[0042] L is an organic group of valency n;

[0043] provided that:

[0044] (i) the compound comprises one or more hydrazide or hydrazine group, preferably of Formula (2), more preferably of Formula (2a) or (2b), as hereinbefore defined; and

[0045] (ii) the compound is free from groups of Formula (1) and salts thereof, as hereinbefore defined.

[0046] The hydrazine and hydrazide group preferably forms part of L and/or R1. Preferably the hydrazine or hydrazide group is attached directly to the triazine ring shown in Formula (3).

[0047] Preferably n is 1, 2, 3 or 4, more preferably 1, 2 or 3, especially 1 or 2.

[0048] Each D independently is preferably an azo (especially mono azo or disazo), formazan, metallised azo, methine, azamethine, xanthene, triphenyl methane, is phthalocyanine or anthraquinone chromophore or a combination thereof.

[0049] Preferred azo chromophores represented by D are of the Formula (4):

Ar—N═N—Y—Z— Formula (4)

[0050] wherein:

[0051] Ar is optionally substituted aryl;

[0052] Y is optionally substituted arylene;

[0053] Z is O, S, a hydrazine group, a hydrazide group or NR2; and

[0054] R2 is H, optionally substituted alkyl, optionally substituted aryl or optionally substituted acyl;

[0055] provided that the group of Formula (4) is free from groups of Formula (1) and salts thereof.

[0056] Ar is preferably optionally substituted phenyl, optionally substituted naphthyl or optionally substituted benzthiazolyl.

[0057] Y is preferably optionally substituted phenylene or optionally substituted naphthylene.

[0058] Suitable substituents on Ar and Y include sulpho, carboxy, —SO3H, —PO3H2, —CF3, optionally substituted C1-10-alkoxy, optionally substituted C1-10-alkyl, azo groups, hydrazide groups, hydrazine groups, especially of Formula (2) as hereinbefore defined, optionally substituted amino, halo, —CN, —OH, —NO2 and —SO2CH═CH2.

[0059] Preferably each Ar has a substituent at the 2-position relative to the azo group shown in Formula (4). Preferably this 2-substituent is —SO3H or —CO2H.

[0060] In a preferred embodiment, R1 is H, OH, a chromophoric group, halo, optionally substituted alkyl, —NR3R4, —N(Q1)-N(Q2)R2, —OR2 or —SR2 wherein:

[0061] each R2, Q1 and Q2 independently is as hereinbefore defined;

[0062] each R3 and R4 independently is H, optionally substituted alkyl, optionally substituted aryl or optionally substituted acyl, or R3 and R4 together with the N atom to which they are attached form an optionally substituted 5- or 6-membered ring.

[0063] Preferred halo groups represented by R1 include F and Cl. When R1 is —NR3R4 it is preferred that each R3 and R4 independently is H, optionally substituted alkyl, optionally substituted aryl or optionally substituted heterocyclyl, or R3 and R4 together with the nitrogen atom to which they are attached form an optionally substituted 5- or 6-membered ring.

[0064] However, especially preferred R1 groups are OH, Cl, —NR3R4 and —N(Q1)-N(Q2)R2 wherein R2, R3, R4, Q1 and Q2 are as hereinbefore defined.

[0065] Examples of groups represented by R1 include —NHCH2CHOHCH2OH, —NH(CH2)2SO3H, —NH(CH2)2O(CH2)2OH, —NCH3CH2CO2H,

[0066] —N H(CH2)9CH3, 'NH(CH2)5OH3, —NH(CH2)7CH3, —NH(CH2)2CH(CH3)3,

[0067] L is preferably an organic linking group (especially a divalent organic linking group) comprising a sulphur, oxygen or nitrogen atom at one or both ends, more preferably an amino group of formula —NR2— or a hydrazine or hydrazide group at one or both ends. Preferably L comprises from 2 to 20, more preferably from 2 to 10 carbon atoms. Thus L is preferably of the formula —X1—(L1—X2)m— wherein:

[0068] m is 0 or 1;

[0069] L1 is an optionally substituted, optionally interrupted alkylene group or an optionally substituted arylene group; and

[0070] X1 and X2 are each independently of the formula —NR2— or a hydrazine or hydrazide group.

[0071] When L1 is an optionally substituted, optionally interrupted alkylene group, it is preferably optionally substituted, optionally interrupted C1-20-alkylene.

[0072] Preferred optional interrupting groups for R2, R3, R4, Q1, Q2 and L1 are selected from —SS—, —CO—, —CS—, —CO2—, phenylene, triazine, —S—, —CH═CH—, hydrazine groups, hydrazide groups and —NR2—, wherein R2 is as hereinbefore defined.

[0073] L1 is preferably —CO—C1-20-alkylene-CO— or —C1-20-alkylene, optionally interrupted by —O—, —S—, —S—, —CO—, —CS—, —CO2—, —CH═CH—, —N(Q1)-N(Q2)- or NR2, wherein R2, Q1 and Q2 are as previously defined, and optionally substituted by —OH or —CO2H.

[0074] When L1 is interrupted, it preferably contains 1 to 5 interrupting groups, more preferably one or two interrupting groups. The interrupting groups may be part way along the alkylene group (e.g. —CH2COCH2) or at the end of the alkylene group (e.g. —CO(CH2)2CO).

[0075] When L1 is an optionally substituted arylene group, then the optional substituents are as previously described. However, more preferably, the arylene group is unsubstituted, and is a phenylene group, especially 1,4-phenylene.

[0076] Examples of suitable groups represented by L include:

—NH—NH—CO(CH2)4CO—NH—NH—

—NH—NH—CO—C6H5—CO—NH—NH—

[0077] When R1, R2, R3, R4, Q1, Q2 or Q4 is optionally substituted, alkyl, it is preferably C1-20-alkyl, more preferably C1-10-alkyl, especially C1-6-alkyl, more especially C1-4-alkyl, each of which is optionally substituted and optionally interrupted. The optional substituents are preferably selected from C1-6-alkoxy, halo (preferably F or Cl) C1-6-hydroxy alkoxy, —OH, —CO2H, —SO3H, —PO3H2, —CN, optionally substituted phenyl, a 5- or 6-membered heterocyclic group and optionally substituted amino.

[0078] Preferred 5- or 6-membered rings and heterocyclic groups include furanyl, pyranyl, pyridyl, pyridinium, tetrahydrofuranyl, thiophenyl and carboxymethyl thiophenyl.

[0079] When R2, R3, R4, Q1, Q2 or Q4 is optionally substituted aryl it is preferably optionally substituted phenyl, naphthyl, thiazolyl, pyridyl, furanyl or pyranyl, more preferably optionally substituted phenyl. The optional substituents are preferably selected from C1-6-alkoxy, halo (preferably F or Cl), OH, —CN, —CO2H, —SO3H, —PO3H2, —NO2, —NH2, —COC1-4-alkyl, —NHCOC1-4-alkyl, —(C1-6-alkylene)O(C1-6-alkylene)OC1-4-alkyl, —(C2-6-alkylene)OC2-4-alkylene)OH, —SO2NH2, —SO2NHC1-4-alkyl, C1-6-alkyl and C1-6-alkyl substituted by OH, —CO2H or —SO3H.

[0080] When R1, R2, R3, R4, Q1, Q2 or Q4 is alkyl substituted by an optionally substituted phenyl group, it is preferably an aralkyl group of the formula

[0081] wherein:

[0082] each R6 independently is C1-4-alkyl, C1-4-alkoxy, halo, —OH, —NH2, —CO2H, —SO3H, or —PO3H2; and

[0083] a is 0to 5.

[0084] Preferably a is 0, 1 or 2.

[0085] Especially preferred aralkyl groups are benzyl and 2-phenylethyl, each of which is optionally substituted by —CO2H, —OH or —SO3H.

[0086] When R3 and R4 together with the nitrogen to which they are attached form an optionally substituted ring it is preferably an optionally substituted 5- or 6-membered ring, more preferably a piperazinyl, piperidinyl or morpholinyl ring. The optional substituents are preferably selected from —OH, —CO2H, —SO3H, —C1-6-alkoxy, —C1-6alkyl and —C1-6-alkyl substituted by —OH, —CO2H or —SO3H.

[0087] R2, R3, R4, Q1, Q2 and Q4 are preferably each independently H or C1-4-alkyl.

[0088] Preferred compounds are of Formula (3) are of Formula (3a), (3b), (3c) or (3d):

[0089] wherein:

[0090] D1 is H or a group of formula —Z—Y—N═N—Ar; and

[0091] each Ar, R1, R2, Z, Y, Q1, Q2, Q3, Q4 and L1 independently is as hereinbefore defined; provided that the compound of Formula (3a), (3b), (3c) or (3d) is free from groups of Formula (1) and salts thereof.

[0092] The preferences for Ar, R1, Z, Y, Q1, Q2, Q3, Q4 and L1 in compounds of Formula (3a), (3b), (3c) or (3d) and the preferred salt forms are as hereinbefore defined for compounds of Formula (3).

[0093] When the compound comprises a single group of Formula (1) or a salt thereof the compound is preferably of Formula (5) or a salt thereof:

[0094] wherein:

[0095] D is H or chromophoric group; and

[0096] Ar, L and R1 are as hereinbefore defined;

[0097] provided that:

[0098] (i) the compound comprises one or more hydrazine or hydrazide groups, preferably of Formula (2), more preferably of Formula (2a) or (2b), as hereinbefore defined;

[0099] (ii) the compound has a single group of Formula (1) or salt thereof, as hereinbefore defined.

[0100] The hydrazine or hydrazide group preferably forms part of -L-D and/or R1, preferably being attached directly to the triazine ring shown in Formula (5).

[0101] In compounds of Formula (5) L is preferably a divalent organic linking group, more preferably a divalent organic linking group comprising a sulphur, oxygen or nitrogen atom at each end, especially an amino group of formula —NR4 or a group of Formula (2a) at one or both ends. Preferably L contains from 2 to 20 carbon atoms more preferably 2 to 10 carbon atoms. Thus in compounds of Formula (5) L is preferably of the formula:

—X3—(L1-X4)m—

[0102] wherein:

[0103] m is 0 or 1;

[0104] L1 is as hereinbefore defined; and

[0105] X3 and X4 are each independently O, S, of the formula —NR4 or Formula (2) (especially (2a)) as hereinbefore defined.

[0106] Thus preferred compounds of Formula (5) are of the Formula (5a), (5b), (5c) or (5d) or a salt thereof:

[0107] wherein:

[0108] Z2 is O, S or NR4;

[0109] R4 is H, optionally substituted alkyl, optionally substituted aryl or optionally substituted acyl; and

[0110] Ar, L1, R1, Q1, Q2, Q3, Q4 and D are as hereinbefore defined and preferred; provided that the compounds of Formula (5a), (5b), (5c) and (5d) comprise a single group of Formula (1) or salt thereof.

[0111] Preferred optionally substituted alkyl, optionally substituted aryl and optionally substituted acyl groups represented by R4 in compounds of Formula (5) are as hereinbefore described.

[0112] Preferably D is H, an azo (especially mono azo or disazo), formazan, metallised azo, methine, azamethine, xanthene, triphenyl methane, phthalocyanine or anthraquinone chromophore or a combination thereof.

[0113] In a preferred embodiment of compounds of Formula (5) R1 is H, OH, halo, optionally substituted alkyl, —NR3R4, —N(Q1)-N(Q2)R2, —OR2, —SR2 or of Formula (2b) as hereinbefore defined wherein p is 0;

[0114] wherein R2, R3, R4, Q1 and Q2 are as hereinbefore defined.

[0115] For the avoidance of doubt, ‘single’ means one and only one, not including two or more.

[0116] In compounds of Formula (5) D is preferably H or an azo (especially mono azo or disazo), formazan, xanthine, methine, azomethine, metallised azo, phthalocyanine or anthraquinone chromophore.

[0117] Preferred azo chromophores represented by D are of the Formula (6) or a salt thereof:

[0118] wherein m is 0 or 1 and Ar independently is as hereinbefore defined, provided that D is not and does not comprise a group of Formula (1) as hereinbefore defined.

[0119] In one embodiment at least one of the hydrazine or hydrazide groups, preferably all of the hydrazine and hydrazide groups, forms part of an in chain link between the group of Formula (1) and a chromophoric group other than a group of Formula (1). In another embodiment at least one of the hydrazine or hydrazide groups, preferably all of the hydrazine and hydrazide groups, are not part of an in chain link between the group of Formula (1) and a chromophoric group other than a group of Formula (1).

[0120] When the compound of the present invention comprises two or more groups of the Formula (1) or salts thereof the compound is preferably of Formula (7) or a salt thereof:

[0121] wherein:

[0122] each Ar, R1 and L are as hereinbefore defined; and

[0123] n is 2 or more;

[0124] provided that:

[0125] (i) the compound comprises one or more hydrazine or hydrazide groups, preferably of Formula (2), more preferably of Formula (2a) or (2b), as hereinbefore defined.

[0126] In compounds of Formula (7), the hydrazine or hydrazide group preferably forms part of -L and/or R1, preferably being attached directly to the triazine ring shown in Formula (7).

[0127] Thus preferred compounds of Formula (7) are of the Formula (7a), (7b), (7c) or (7d) or a salt thereof:

[0128] wherein:

[0129] Z2, R4, L1, Ar, R1, Q1, Q2, Q3, Q4 and D and the preferences for these integers are as hereinbefore defined and n is 2 or more.

[0130] In compounds of Formula (7) n is preferably 2, 3 or 4, more preferably 2 or 3, especially 2.

[0131] When the compound of Formula (7) contains a further chromophoric group in addition to the two or more groups of Formula (1) this chromophoric group is preferably H or an azo (especially mono azo or disazo), formazan, xanthine, methine, azomethine, is metallised azo, phthalocyanine or anthraquinone chromophore. Preferred azo chromophores are of the Formula (6) as previously defined.

[0132] In a preferred embodiment of the compounds of Formula (7):

[0133] n is 2;

[0134] L is —NH—NHCO-phenylene-CONH—NH—;

[0135] Ar is phenyl or naphthyl having 0, 1, 2 or 3 substituents selected from the group consisting of carboxy, sulpho and C1-4-alkyl; and

[0136] R1 is H or C1-4-alkyl.

[0137] The compounds may exist in tautomeric forms other than those shown in this specification, for example the hydrazo tautomer. These tautomers are included within the scope of the present claims.

[0138] Preferably the composition comprises 0.1 to 20, more preferably from 0.5 to 15, and especially from 1 to 5 parts of component (a) and from 99.9 to 80, more preferably from 99.5 to 85, especially from 99 to 95 parts of component (b), wherein all parts are by weight and the total number of parts of (a)+(b)=100.

[0139] Preferably component (b) is completely dissolved in component (a). Preferably component (b) has a solubility in component (a) at 20° C. of at least 10%. This allows the preparation of concentrates which may be used to prepare more dilute inks and reduces the chance of the dye precipitating if evaporation of the liquid medium occurs during storage.

[0140] When the medium comprises a mixture of water and an organic solvent, the weight ratio of water to organic solvent is preferably from 99:1 to 1:99, more preferably from 99:1 to 50:50 and especially from 95:5 to 80:20.

[0141] It is preferred that the organic solvent present in the mixture of water and organic solvent is a water-miscible organic solvent or a mixture of such solvents. Preferred water-miscible organic solvents include C1-6alkanols, preferably methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, tert-butanol, n-pentanol, cyclopentanol and cyclohexanol; linear amides, preferably dimethylformamide or dimethylacetamide; ketones and ketone-alcohols, preferably acetone, methyl ether ketone, cyclohexanone and diacetone alcohol; water-miscible ethers, preferably tetrahydrofuran and dioxane; diols, preferably diols having from 2 to 12 carbon atoms, for example pentane-1,5-diol, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol and thiodiglycol and oligo- and poly-alkyleneglycols, preferably diethylene glycol, triethylene glycol, polyethylene glycol and polypropylene glycol; triols, preferably glycerol and 1,2,6-hexanetriol; mono-C1-4-alkyl ethers of diols, preferably mono-C1-4-alkyl ethers of diols having 2 to 12 carbon atoms, especially 2-methoxyethanol, 2-(2-methoxyethoxy)ethanol, 2-(2-ethoxyethoxy)-ethanol, 2-[2-(2-methoxyethoxy)ethoxy]ethanol, 2-[2-(2-ethoxyethoxy)-ethoxy]-ethanol and ethyleneglycol monoallylether; cyclic amides, preferably 2-pyrrolidone, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, caprolactam and 1,3-dimethylimidazolidone; cyclic esters, preferably caprolactone; sulphoxides, preferably dimethyl sulphoxide and sulpholane. Preferably the liquid medium comprises water and 2 or more, especially from 2 to 8, water-miscible organic solvents.

[0142] Especially preferred water-soluble miscible organic solvents are cyclic amides, especially 2-pyrrolidone, N-methyl-pyrrolidone and N-ethyl-pyrrolidone; diols, especially 1,5-pentane diol, ethyleneglycol, thiodiglycol, diethyleneglycol and triethyleneglycol; and mono-C1-4-alkyl and C1-4-alkyl ethers of diols, more preferably mono-C1-4-alkyl ethers of diols having 2 to 12 carbon atoms, especially 2-methoxy-2-ethoxy-2-ethoxyethanol.

[0143] Examples of further suitable ink media comprising a mixture of water and one or more organic solvents are described in U.S. Pat. No. 4,963,189, U.S. Pat. No. 4,703,113, U.S. Pat. No. 4,626,284 and EP 4,251,50A.

[0144] When the liquid medium comprises an organic solvent free from water, (i.e. less than 1% water by weight) the solvent preferably has a boiling point of from 30° to 200° C., more preferably of from 40° to 150° C., especially from 50 to 125° C. The organic solvent may be water-immiscible, water-miscible or a mixture of such solvents. Preferred water-miscible organic solvents are any of the hereinbefore described water-miscible organic solvents and mixtures thereof. Preferred water-immiscible solvents include, for example, aliphatic hydrocarbons; esters, preferably ethyl acetate; chlorinated hydrocarbons, preferably CH2Cl2; and ethers, preferably diethyl ether; and mixtures thereof.

[0145] When the liquid medium comprises a water-immiscible organic solvent, preferably a polar solvent is included because this enhances solubility of the dye in the liquid medium. Examples of polar solvents include C1-4-alcohols. In view of the foregoing preferences it is especially preferred that where the liquid medium is an organic solvent free from water it comprises a ketone (especially methyl ethyl ketone) &/or an alcohol (especially a C1-4-alkanol, more especially ethanol or propanol).

[0146] The organic solvent free from water may be a single organic solvent or a mixture of two or more organic solvents. It is preferred that when the medium is an organic solvent free from water it is a mixture of 2 to 5 different organic solvents. This allows a medium to be selected which gives good control over the drying characteristics and storage stability of the ink.

[0147] Liquid media comprising an organic solvent free from water are particularly useful where fast drying times are required and particularly when printing onto hydrophobic and non-absorbent substrates, for example plastics, metal and glass.

[0148] Preferred low melting solid media have a melting point in the range from 60° C. to 125° C. Suitable low melting point solids include long chain fatty acids or alcohols, preferably those with C18-24 chains, and sulphonamides. The compounds defined in the first aspect of the invention may be dissolved in the low melting point solid or may be finely dispersed in it.

[0149] The composition may also contain additional components conventionally used in ink jet printing inks, for example viscosity and surface tension modifiers, corrosion inhibitors, biocides, kogation reducing additives and surfactants which may be ionic or non-ionic.

[0150] The composition may be used as a concentrate to make ink jet printing inks or, more preferably, the composition is an ink, especially an ink jet printing ink.

[0151] The compositions may be, and preferably are, purified to remove undesirable impurities. Conventional techniques may be employed for purifying the compounds, for example ultrafiltration, reverse osmosis and/or dialysis. Thus the compositions of the present invention preferably have a total concentration of divalent and trivalent metal ions of less that 500 ppm, more preferably less than 100 ppm, especially less than 20 ppm, where ppm refers to parts per million by weight.

[0152] Preferably the composition of the present invention have been filtered through a filter having a mean pore size below 10 μm, more preferably below 2 μm, especially below 1 μm.

[0153] According to a second aspect of the present invention there is provided a compound as defined in the first aspect of the present invention, provided that the compound is free from halotriazine groups and/or the hydrazine or hydrazide groups are of Formula (2a) or (2b) as hereinbefore defined wherein p is 1 and/or the compound comprises at least one water-solubilising group.

[0154] The preferences described above in relation to the preferred compounds to be included in the compositions according to the first aspect of the present invention also apply to the compounds per se according to the second aspect of the present invention.

[0155] The preferences for the compounds of the second aspect of the present invention are as hereinbefore described for the compounds used as component (b) according to the first aspect of the present invention (especially preferred are the compounds of Formulae (3), (5) and (7)) provided that the compound is in all cases free from halotriazine groups.

[0156] The compounds of the invention may be prepared by methods analogous to those used in the field of ink jet printing except that at least one of the starting materials is selected which contains a hydrazine and/or hydrazide group and which is (i) either free from groups of Formula (1) or salts thereof; (ii) comprises a single group of Formula (1) or a salt thereof; or (iii) comprises two or more groups of Formula (1) or salts thereof in the compound. For example known compounds having labile groups and one group of Formula (1), e.g. reactive dyes as disclosed in the Colour Index International, may be condensed with hydrazine or hydrazide compounds at pH below 7. The Examples described later in this specification illustrate more specifically the reaction conditions which may be employed to make compounds of the invention.

[0157] A third aspect of the invention provides a process for the coloration of a substrate comprising applying thereto by means of an ink jet printer a composition according to the first aspect of the present invention or a compound according to the second aspect of the present invention.

[0158] The ink jet printer preferably applies the composition to the substrate in the form of droplets which are ejected through a small orifice onto the substrate. Preferred ink jet printers are piezoelectric ink jet printers and thermal ink jet printers. In thermal ink jet printers, programmed pulses of heat are applied to the composition in a reservoir by means of a resistor adjacent to the orifice, thereby causing the composition to be ejected in the form of small droplets directed towards the substrate during relative movement between the substrate and the orifice. In piezoelectric ink jet printers the oscillation of a small crystal causes ejection of the composition from the orifice.

[0159] The substrate is preferably paper, plastic, a textile, metal or glass, more preferably paper, an overhead projector slide, especially paper, more especially a porous paper.

[0160] Preferred papers are plain or treated papers (especially porous papers) which may have an acid, alkaline or neutral character. Examples of commercially available treated papers include HP Premium Coated Paper, HP Photopaper (all available from Hewlett Packard Inc.), Stylus Pro 720 dpi Coated Paper, Epson Premium Glossy Photopaper. Epson Photo Quality Gloss Film, Epson Photo Quality Glossy Paper (available from Seiko Epson Corp.), Canon HR 101 High Resolution Paper, Canon GP 201 Glossy Paper, Canon HG 101 High Gloss Film (all available from Canon Inc.), Wiggins Conqueror Paper (available from Wiggins Teape Ltd), Xerox Acid Paper and Xerox Alkaline Paper, Xerox Acid Paper (available from Xerox).

[0161] Preferred porous papers comprise;

[0162] (a) an inorganic absorbent pigment, preferably silica or alumina; and

[0163] (b) a binder resin.

[0164] The binder resin preferably comprises polyvinylalcohol, polyvinyl pyrrolidone or a mixture thereof.

[0165] The preference for porous papers arises because these papers, in combination with the compounds and compositions of the present invention, lead to prints having particularly good light-fastness properties.

[0166] The preference for porous papers arises because these papers, in combination with the compounds and compositions of the present invention, lead to prints having particularly good light-fastness properties.

[0167] A fourth aspect of the present invention provides a substrate, preferably a paper, a slide or a textile material printed with a composition according to the first aspect of the present invention, by a compound according to the second aspect of the present invention, or by means of a process according to the third aspect of the present invention.

[0168] According to a fifth aspect of the present invention there is provided an ink jet printer cartridge comprising a chamber and ink, wherein the ink is present in the chamber and the ink comprises a composition according to the first aspect of the present invention or a compound according to the second aspect of the invention.

[0169] According to a sixth aspect of the present invention there is provided an ink jet printer containing an ink jet printer cartridge, wherein the ink jet printer cartridge is as defined in the fifth aspect of the present invention.

[0170] The invention is further illustrated by way of the following examples in which all parts and percentages are by weight unless otherwise stated.

EXAMPLE 1

Preparation of a Compound of Formula (A) wherein R1 is —NHCH2CHOHCH2OH and -L1-D1 is —CONH2

[0171]

[0172] Stage (a)

[0173] C.I Acid Red 34 (144 g, 0.2 mol, available from sources indicated in the Colour Index International) was dissolved in de-ionised water (1.51) and screened through GF/A filter paper to ensure a solution cooled and stirred at 0-5° C.

[0174] A few drops of calsolene oil were added, followed by cyanuric chloride. The mixture was stirred for ˜2 hours, the pH was then raised to 6.5 to 7 using 2N sodium hydroxide, then screened through GF/A filter paper to remove excess cyanuric chloride.

[0175] 1-amino-2,3-propanediol (0.22 mol) was added with stirring at −30° C., whilst the pH was maintained at 8.5, controlled with 2N sodium hydroxide. A sample was examined by HPLC and was deemed to be satisfactory. The mixture was cooled to room temperature and isolated by addition to acetone (˜7.5 l), then filtered and pulled fairly dry. The product obtained was dried under vacuum at room temperature, giving a magenta solid (147.9 g).

[0176] Stage (b)

[0177] The product of stage (a) (40 g) was stirred in de-ionised water (350 ml) along with H2NNHCONH2 (14.19) at ˜30° C., whilst the pH was maintained at ˜8.5 using 2N sodium hydroxide. Progress of the reaction was found to be satisfactory by HPLC after ˜10 hours reaction time. The product was then cooled to room temperature and isolated by addition to Methylated Spirits 74 OP (˜2.51), and filtered through GF/A filter paper then pulled fairly dry. The resultant solid was re-dissolved in de-ionised water (˜300 ml) and dialysed to low conductivity using visking tubing. The resultant solution was filtered through GF/A, then GF/F filter paper and finally through Nylon 0.45 microns. The resultant solution was evaporated to dryness under reduced pressure, giving the title product as a magenta solid (32.4 g).

EXAMPLE 2

Preparation of a Compound of Formula (A) wherein R1 is —NHCH2CH2SO3H and -L1-D1 is —CONH2

[0178] The method of Example 1 was repeated except that in place of H2NCH2CHOHCH2OH there was used an equimolar amount of H2NCH2CH2SO3H.

EXAMPLE 3

Preparation of a Compound of Formula (A) wherein R1 is —N(CH2COH)(CH2PO3H2) and -L1-D1 is CONH2

[0179] The method of Example 1 was repeated except that in place of H2NCH2CHOHCH2OH there was used an equimolar amount of —HN(CH2CO2H)(CH2PO3H2).

EXAMPLE 4

Preparation of a Compound of Formula (A) wherein R1 is —N(CH2COH)(CH2PO2H2) and -L1-D1 is COCONH2

[0180] The method of Example 1 was repeated except that in place of H2NCH2CHOHCH2OH there was used an equimolar amount of HN(CH2CO2H)(H2PO3H2) and in place of H2NNHCONH2 there was used H2NNHCOCONH2.

EXAMPLE 5

Inks and Ink Jet Printing

[0181] The compound from Example 3 was made up into an ink according to the formulation shown below. For comparison purposes a compound lacking the hydrazo (—NH—NH—) group, shown below as Comparative Dye (X), was made into an identical ink:

[0182] The ink formulation had a pH8 and the following components (all parts by weight)

1ComponentAmountCompound3.52-pyrrolidone5thiodiglycol5Surfynol ™ 4651Water85.5

[0183] The inks were placed in a Canon 4300 ink jet printer and printed onto the papers indicated in Table 1 below. After drying, the light fastness of the prints were measured by radiating the papers in an Atlas Ci 5000 Weatherometer and recording the level of fade (ΔE). A high value of ΔE indicates low light fastness and a low value of ΔE indicates high light fastness. The results of these measurements are shown in Table 1 below:

2TABLE 1CompoundPaperΔEExample 3Kodak photo paper5Comparative Dye (X)Kodak photo paper79Example 3GP30116Comparative Dye (x)GP30135

[0184] Table 1 shows that compounds of the invention have higher light fastness (lower ΔE) than Comparative Dye (X).

EXAMPLE 7

Preparation of the Compound of Formula (A1) wherein R1 is OH and -L-D is —NH—NH—COCONH2

[0185]

[0186] Stage (a) Preparation of Dichlorotriazine Compound

[0187] Stage a

[0188] 1-Amino-8-hydroxy-3,6-disulpho-2-(2-carboxy phenyl azo)napthalene (prepared as described in European Patent Application No. 682088 A1, page 17, lines 50 to 53) (5 parts) was suspended in water (50 parts) and dissolved by the addition of 2M sodium hydroxide solution to pH7. The solution was cooled to 0-5° C. and a slurry of cyanuric chloride (5.5 part) in water (50 mls) containing calsolene oil (0.1 g). The resulting mixture was stirred for 2 hours at 0-5° C. and the pH of the mixture was maintained at 6.5-7 by the addition of 2M sodium hydroxide solution as required, to give the dichlorotriazinyl compound.

[0189] Stage (b)—Reaction with Hydrazine

[0190] Stage b

[0191] Oxamic hydrazide (1 part) was added to a solution of the dichorotriazine (1part) and the pH of the mixture raised to 8.5 with 2M sodium hydroxide solution. The temperature was allowed to rise to 20-25° C. and the mixture stirred at pH 8.5/20-25° C. for 2.5 hours.

[0192] Stage (c)—Conversion of R4═Cl to R4═OH

[0193] Stage c

[0194] 1,4-diazabicyclo[2.2.2]octane (0.01 parts) was added to a solution of the monochlorotraizine in water (1 part in 10) and the pH was raised to 10.5-11.0 with 2M sodium hydroxide solution. The mixture was heated to 80-85° C. and held there until the hydrolysis was complete. Sodium chloride was added to 10% w/v and the pH brought to 7 with concentrated hydrochloric acid. The mixture was cooled to 60° C., the product was is filtered off and washed with 15% w/v sodium chloride solution. The wet product was dissolved in dilute sodium hydroxide solution and dialysed in visking tubing to low conductivity. The dialysed solution was screened through a 0.71 μm filter and the solution evaporated to dryness at 50° C. to give the title compound.

[0195] The resultant compound had a λ max at 553 nm.

EXAMPLES 8 TO 38

[0196] The method of Example 7 was repeated except that in step (b), in place of oxamic hydrazide there was used an equimolar amount of the hydrazine specified in Table 2, column 2. The resultant compound was of Formula (A1) wherein R1 and -L-D are as specified in Table 2.

3TABLE 2Resultant CompoundExampleHydrazine-L-DR18H2NNHCO(CH2)6CH3HNNHCO(CH2)6CH3—OH9

—OH10

—OH11H2NNHCOC6H5HNNHCOC6H5—OH12

—OH13

—OH14H2NNHCONHC6H5—HNNHCONHC6H5—OH15H2NNHCONH2—HNNHCONH2—OH16H2NNHCOCH3—HNNHCOCH3—OH17

—OH18

—OH19H2NNHCOCHN+(CH3)3—HNNHCOCH2N+(CH3)3—OH20H2NNHC6H5—NHNHC6H5—OH21H2NNH(CH2CH2)2NCH3—NHN(CH2CH2)2NCH3—OH22

—OH23H2NNHCH2CH2OH—HNNHCH2CH2OH—OH24H2NNHCOCH2C6H5—NHNHCOCH2C6H5—OH25

—OH26

—OH27H2NNHCH2C6H5—HNNHCH2C6H5—OH28

—OH29

—OH30

—OH31H2NNHCH3—NHNHCH3—OH32H2NNHCOCH2CN—NHNHCOCH2CN—OH33

—OH34H2NNHC(CH3)3—NHNHC(CH3)3—OH35

—OH36

—OH37

—OH38

—Cl**hydrolysis step omitted

EXAMPLES 39 TO 62

[0197] The method of Example 7 was repeated except that in stage (b) place of oxamic hydrazide there was used an equivalent amount of the hydrazine compound specified in Table 3, column 2, and stage (c) was replaced by condensation of the product of stage (b) (1 part) in water (10 parts) at 85° C. with the nucleophile (3 parts) listed in Table 3, column 3. The resultant compound was of the Formula (A1) wherein R1 and -L-D are as in Table 3.

4TABLE 3Ex-am-Resultant Compoundplehydrazinenucleophile-L-DR139H2NNHCOC6H5H2NCH2CHOHCH2OH—NHNHCOC6H5—NHCH2CHOHCH2OH40

H2NCH2CHOHCH2OH

—NHCH2CHOHCH2OH41H2NNHCOCH3H2NCH2CHOHCH2OH—HNNHCOCH3—NHCH2CHOHCH2OH42H2NNHCOCONH2H2NCH2CHOHCH2OH—HNNHCOCONH2—NHCH2CHOHCH2OH43H2NNHCOCH3

—HNNHCOCH3

44H2NNHCOCONH2

—HNNHCOCONH2

45H2NNHCOC6H5

—NHNHCOC6H5

46H2NNHCOCH3

—NHNHCOCH3

47H2NNHCOC6H5H2NCH2PO3H—HNNHCOC6H5—NHCH2PO3H48

H2NNHCONH2

—NHNHCONH249H2NNHCOCH3

—NHNHCOCH3

50H2NNHCO(CH2)6CH3H2N(CH2)5CO2H—NHNHCO(CH2)6CH3—NH(CH2)5CO2H51H2NNHCO(CH2)6CH3H2N(CH2)5CH3—NHNHCO(CH2)6CH3—NH(CH2)5CH352H2NNHCO(CH2)6CH3

—NHNHCO(CH2)6CH3

53H2NNHCO(CH2)6CH3H2NCH2CH2CO2H—NHNHCO(CH2)6CH3—NHCH2CH2CO2H54

H2N(CH2)5OH

—NH(CH2)5OH57

H2N(CH2)3N(CH3)2

—NH(CH2)3N(CH3)258

H2N(CH2CH2O)2H

—NH(CH2CH2O)2H59

H2N(CH2CH2O)2H

—NH(CH2CH2o)2H60

61H2NNHCO(CH2)6CH3

—NHNHCO(CH2)CH3

EXAMPLES 63 TO 125

[0198] The method of the Example specified in Table 4, column 2, was repeated except that in place of the compound specified in column 3 there was used an equimolar amount of the compound specified in column 4. The resultant compound was Formula (B) wherein Ar, R1 and -L-D are as specified in Table 4.

5TABLE 4PreviousPreviousExampleExampleCompoundReplaced byArR1-L-D6312-carboxy aniline2-sulpho-4-methyl aniline

—OH—NHNHCOCONH26412-carboxy aniline1-sulpho-2-amino naphthalene

—OH—NHNHCOCONH26552-carboxy aniline2-carboxy-4- methyl aniline

—OH—NHNHCOC6H566102-carboxy aniline2-carboxy-4- methyl aniline

—OH—NHNHCOCH36742-carboxy aniline2-carboxy-4- methyl aniline

—OH

100

6812-carboxy aniline2-carboxy-4- methyl aniline

101

—OH—NHCOCONH26932-carboxy aniline1-sulpho-2-amino naphthalene

102

—OH

103

7012-carboxy aniline1 -sulpho-5- acetamido aniline

104

—OH—NHNHCOCONH27172-carboxy aniline2-hydroxymethyl aniline

105

—OH

106

7262-carboxy aniline2-hydroxymethyl aniline

107

—OH

108

7342-carboxy aniline2-hydroxymethyl aniline

109

—OH

110

74142-carboxy aniline2-hydroxymethyl aniline

111

—OH—NHNHC6H575232-carboxy aniline2-hydroxymethyl aniline

112

—OH—NHNHC6H4Cl76102-carboxy aniline2-hydroxymethyl aniline

113

—OH—NHNHCOCH377132-carboxy aniline2-hydroxymethyl aniline

114

—OH—NHNHCOCH2N(CH3)378182-carboxynl aniline2-hydroxymethyl aniline

115

—OH—NHNHCH2C6H579192-carboxy aniline2-hydroxymethyl aniline

116

—OH—NHNHC6H4F8072-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

117

8162-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

118

8242-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

119

8352-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCOC6H5anilineanilinephenyl84242-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

120

85232-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

121

86102-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCOCH3anilineanilinephenyl87262-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCOanilineanilinephenyl88182-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCOCH2C6H5anilineanilinephenyl89172-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCH2CH2Oanilineanilinephenyl9022-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCO(CH2)6CH3anilineanilinephenyl91132-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCOCH2N+(CH3)3anilineanilinephenyl92212-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHCH2C8H5anilineanilinephenyl93102-carboxy aniline2-sulpho-4-methyl aniline

122

—OH—NHNHCOCH394132-carboxy aniline2-sulpho-4-methyl aniline

123

—OH—NHNHCON(CH3)395272-carboxy 2-sulpho-4-methyl

124

—OH

125

96122-carboxy aniline1-sulpho-2-methyl aniline

126

—OH

127

97132-carboxy aniline1-sulpho-2-amino naphthalene

128

—OH—NHNHCON+(CH3)39842-carboxy aniline3-carboxy-6- methoxy aniline3-carboxy-6- methoxy phenyl—OH

129

9972-carboxy aniline3-carboxy-6- methoxy aniline3-carboxy-6- methozy phenyl—OH

130

100202-carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—OH

131

10142-carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—OH

132

102182-carboxy2-sulpho-4-methyl2-sulpho-4-methyl—OH—NHNHCOCH2C6H5anilineanilinephenyl103212-carboxy2-sulpho-4-methyl2-sulpho-4-methyl—OH—NHNHCH2C6H5anilineanilinephenyl104192-carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—OH

133

105282-carboxy2-sulpho-4-methyl2-sulpho-4-methyl—OH

134

anilineanilinephenyl106142-carboxy2-sulpho-5-amino2-sulpho-5-amino—OH—NHNHC6H5anilineanilinephenyl107142-carboxy2-sulpho-4-2-sulpho-4-—OH—NHNHC6H5anilinemethoxy anilinemethoxy phenyl108142-carboxy2-carboxy-4-2-carboxy-4-—OH—NHNHC6H5anilinemethyl anilinemethylphenyl10922-carboxy2-hydroxy methyl2-hydroxy methyl—OH—NHNHCO(CH2)6CH3anilineanilinephenyl110282-carboxy2-hydroxy methyl2-hydroxy methyl—OH—NHNHC(CH3)3anilineanilinephenyl11142-carboxy aniline1-sulpho-2-amino napthalene

135

—OH

136

112102-carboxy aniline1-sulpho-2-amino napthalene

137

—OH—NHNHCOCH3113202-carboxy aniline1-sulpho-2-amino napthalene

138

—OH

139

114182-carboxy aniline1-sulpho-2-amino napthalene

140

—OH—NHNHCOCH2C6H511522-carboxy aniline1-sulpho-2-amino napthalene

141

—OH—NHNHCO(CH2)6CH3116212-carboxy aniline1-sulpho-2-amino napthalene

142

—OH—NHNHCH2C6H5117192-carboxy aniline1-sulpho-2-amino napthalene

143

—OH

144

118282-carboxy aniline1-sulpho-2-amino napthalene

145

—OH—NHNHC(CH3)3119192-carboxy aniline3,5-dicarboxy aniline3,5-dicarboxy phenyl—OH

146

120282-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHC(CH3)3anilineanilinephenyl121142-carboxy3,5-dicarboxy3,5-dicarboxy—OH—NHNHC6H5anilineanilinephenyl12222-carboxy3-carboxy-6-3-carboxy-6-—OH—NHNHCO(CH2)6CH3anilinemethoxy anilinemethoxy phenyl123242-carboxy aniline1-sulpho-2-amino napthalene

147

—OH

148

124262-carboxy aniline1-sulpho-2-amino napthalene

149

—OH—NHNHCOCH2CN125412-carboxy aniline1-sulpho-2-amino napthalene

150

—NHCH2PO3H—NHNHCOC6H5

EXAMPLES 126 TO 136

[0199] The method of Example 7 was represented except that in stage (a) place of 2-carboxy aniline the compound specified in Table 5, column 3 was used in an equimolar amount; and in stage (b) in place of oxamic acid there was used an equimolar amount of the hydrazine in Table 5, column 6.

6TABLE 5Pre-Pre-viousviousCom-Com-ExpoundReplaced byArpoundReplaced by-L-D1262- carboxy aniline1-sulpho-2-amino napthalene

151

—

152

153

1272- carboxy aniline2-hydroxy methyl aniline2-hydroxy methyl phenol—

154

155

1282- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—

156

157

1292- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—

158

159

1302- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—

160

161

1312- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—

162

163

1322-3-carboxy-6-methoxy aniline3-carboxy-6-methoxy phenyl—NH2NHCOCONH2—NHNHCOCONH2carboxyaniline1332- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl—

164

165

1342- carboxy aniline2-sulpho-4-methyl aniline2-sulpho-4-methyl phenyl—

166

167

1352- carboxy aniline2,5-dicarboxy aniline2,5-dicarboxy phenyl—

168

169

1362- carboxy aniline

170

171

——NH2NHCOCONH2—NHNHCOCONH2

EXAMPLES 137 TO 141

[0200] The method of Example 7 was repeated except that in stage (a) in place of 2-carboxy aniline the compound specified in Table 6, column 2 was used in an equimolar amount; in stage (b) in place of oxamic acid there was used an equimolar amount of the hydrazine in Table 6, column 7; and stage (c) was replaced by condensation of the product of stage (b) (1 part) in water (10 parts) at 85° C. with the nucleophile listed in Table 6, column 5.

7TABLE 6PreviousReplacedExCompoundbyArNucleophileR41372-carboxy3-carboxy-6-3-carboxy-6-NH2CH2CH2CH(CH3)2—NHCH2CH2CH(CH3)2anilinemethoxymethoxyanilinephenyl1382-carboxy aniline1-sulpho-2- amino napthalene

172

NH2CH2CH(OH)CH2OH—NHCH2CH(OH)CH2OH1392-carboxy aniline1-sulpho-2- amino napthalene

173

174

175

1402-carboxy aniline1-sulpho-2- amino napthalene

176

NH2NHCOC6H5—NHNHCOC6H51412-carboxy aniline1-sulpho-2- amino napthalene

177

NH2PO3H2—NHPO3H2PreviousReplacedExCompoundby-L-D137—NH2NHCO(CH2)6CH3—NHNHCO(CH2)6CH3138——NH2NHCOCH2N+(CH3)3—NHNHCOCH2N+(CH3)3139—NH2NHCOCH3 —NHNHCOCH3140—NH2NHCO(CH2)6CH3—NHNHCO(CH2)CH3141—

178

179

EXAMPLE 142

Inks and Ink Jet Printing

[0201] The compound from Example 7 was made up into an ink according to the formulation shown below. For comparison purposes a compound lacking the hydrazo (—NH—NH—) group, shown below as Comparative Dye (X), was made into an analogous ink:

180

[0202] The ink Formulation had a pH8 and the following components (all parts by weight):

8ComponentAmountCompound3.52-pyrrolidone5thiodiglycol5Surfynol ™ 4651Water85.5

[0203] The inks were placed in a Canon 4300 ink jet printer and printed onto the papers indicated in Table 7 below. After drying, the light fastness of the prints were measured by radiating the papers in an Atlas Ci 5000 Weatherometer and recording the level of fade (ΔE). A high value of ΔE indicates low light fastness and a low value of ΔE indicates high light fastness. The results of these measurements are shown in Table 7 below:

9TABLE 7CompoundPaperΔEExample 1Canon HG 2018Comparative Dye (X)Canon HG 20122

[0204] Table 7 shows that compound containing a hydrazine or hydrazide group has a higher light fastness (lower ΔE) than Comparative Dye (X).

EXAMPLE 143

Preparation of Compound (A2)

[0205]

181

[0206] Compound (A2) was prepared as follows:

[0207] 1-Amino-8-hydroxy-3,6-disulpho-2-(2-carboxy phenylazo) naphthalene (prepared as described in European Patent application number EP682088 A1 page 17, lines 50 to 53 (5 parts) was suspended in water (50 parts) and dissolved by the addition of 2M sodium hydroxide solution to pH7. The solution was cooled to 0-5° C. and a slurry of cyanuric chloride (5.5 part) in water (50 mls) containing calsolene oil (0.1 g). The resulting mixture was stirred for 2 hours at 0-5° C. and the pH of the mixture was maintained at 6.5 to 7 by the addition of 2M sodium hydroxide solution as required. Oxalic acid dihydrazide (2.74 parts) was added and the pH of the mixture raised to 8.5 with 2M sodium hydroxide solution. The temperature was allowed to rise to 20-25° C. and the mixture stirred at pH 8.5/20-25° C. for 2.5 hours. 1,4-diazabicyclo[2.2.2]octane (0.2 g) was added and the pH was raised to 10.5-11.0 with 2M sodium hydroxide solution. The mixture was heated to 80-85° C. and held there until the hydrolysis was complete. Sodium chloride was added to 10% w/v and the pH brought to 7 with concentrated hydrochloric acid. The mixture was cooled to 60° C., the product was filtered off and washed with 15% w/v sodium chloride solution. The wet product was dissolved in dilute sodium hydroxide solution and dialysed in visking tubing to low conductivity. The dialysed solution was screened through a 0.7 μm filter and the solution evaporated to dryness at 50° C. to give the title compound.

EXAMPLES 144 TO 148

[0208] The method of Example 143 was repeated except that in place of the component(s) listed in Table 8, column 2, there was used an equimolar amount of the component(s) listed in column 3. The resultant compound was of Formula (B1) wherein Ar and L1 are as shown in Table 8.

182

10TABLE 8Component fromResultant CompoundExampleExample 143Replaced byArL1144(CONHNH2)2[(CH2)2CONHNH2]22-carboxyphenyl—CO(CH2)4—CO—145(CONHNH2)2[(CH2)2CONHNH2]21-sulphonaphth-2-yl—CO(CH2)4—CO—2—Carboxyaniline1-sulpho-2-aminonaphthalene1462—Carboxyaniline1-sulpho-2-1-sulphonaphth-2-yl—COCO—aminonaphthalene147(CONHNH2)22-methyl-4,5- di(CO NHNH2)imidazole2-carboxyphenyl

183

148(CONHNH2)22—Carboxyaniline1,4-di(CO NHNH2)benzene 1-sulpho-2- aminonaphthalene1-sulphonaphth-2-yl

184

EXAMPLE 149

[0209] Preparation of:

185

[0210] The title compound was prepared as described in Example 143 except that in place of oxalic acid dihydrazide there was used an equimolar amount of pterephthaloyl dihydrazide and the hydrolysation step was omitted. The resultant compound had a λmax 548 nm.

EXAMPLES 150 To 155

[0211] The compounds of Formula (C) described in Table 9 below were prepared by condensing the compound resulting from Example 149 (1 part) in water (10 parts) with an excess of the amine indicated in Table 9, column 2 (3 parts) at 80° C. for 4 hours.

186

11TABLE 9Resultant CompoundExam-λmaxpleAmineR4(nm)150decylamine—NH(CH2)9CH3542151hexylamine—NH(CH2)5CH3544152morpholineMorpholine540153octylamine—NH(CH2)7CH3544154H2NCH2CH2CH(CH3)2—NHCH2CH2CH(CH3)2542155furfurylamine

187

540

EXAMPLES 156 TO 159

[0212] The method of Example 143 was repeated except that (i) oxalic acid dihydrazide was replaced by an equimolar amount of [(CH2)2CONHNH2]2 and the hydrolysation step was replaced by condensation of the resultant chlorotriazine compound (1 part) with the amine indicated in Table 10, column 2 below (3 parts) in water at 80° C. for 4 hours.

[0213] The resultant compounds were of Formula (D) wherein R4 is as defined in Table 10 below.

12TABLE 10

188

Formula (D)Resultant CompoundExampleAmineR4λmax (nm)156H2NCH2CHOHCH2OH—NHCH2CHOHCH2OH548157H2NCH2CH2SO3H—NHCH2CH2SO3H549158CH3NHCH2CO2H—N(CH3)CH2CO2H5471592-carboxypyrrole

189

EXAMPLE 160

[0214] Preparation of the compound of Formula (E) wherein R4 is Cl and L1 is —CO(CH2)4CO—

190

[0215] Stage (i)

[0216] 2-Napthylamine-1-sulphonic acid (67.84 g) was added to water (500 ml) and cooled to 0-5° C. Concentrated HCl (150 ml) was then added followed by 2N NaNO2 (150 ml). The solution was stirred for 1 hour at 0-5° C. and excess NaNO2 was destroyed by addition of sulphamic acid.

[0217] To the above solution was added 1-acetamido-8-napthol-3,6-disulphonic acid (109.83 g) in water (500 ml). The pH was then raised to 7 by addition of a concentrated solution of NaOH and the solution was stirred for 3 hours at 0 to 5° C. The solution was then adjusted to pH11 by addition of NaOH pellets and was heated to 85° C. for 6 hours.

[0218] The pH was then reduced to 7.0 by addition of concentrated HCl and the solution was salted to 20% with NaCl. The resulting precipitate was filtered off, washed and dried.

[0219] Stage (ii)

[0220] The product of stage (i) above (86.5 g) was dissolved in water (800 ml). Cyanuric chloride (19.36 g) was dissolved in acetone (200 ml) and added to ice/water (300 g). To this was added the solution of the product of stage (i) allowing the pH to fall. The resulting solution was stirred for 2 hours at 0-5° C. The pH was then raised to 7.0 by addition of 2N NaOH solution and the solution was allowed to self warm to room temperature. This gave a dichorotriazine compound.

[0221] Stage (iii)

[0222] Adipic dihydrazide (0.5 parts) was added to a solution of the dichlorotriazine product from stage (ii) (1 part) in water (10 parts) and the pH of the mixture raised. to 8.5 with 2M sodium hydroxide solution. The temperature was allowed to rise to 20-25° C. and the mixture stirred at pH 8.5/20-25° C. for 2.5 hours to give the title product.

EXAMPLE 161 TO 166

[0223] The resultant compounds were of Formula (E) wherein R4 and L1 are as described in Table 11 below. These compounds were prepared by condensing 3 parts of the nucleophile listed in column 2 of Table 11 with 1 part of the product of Example 160 in water (10 parts) at 85° C. for 4 hours.

13TABLE 11Resultant CompoundExampleNucleophileR4L1161H2NCH2CH2SO3H—NHCH2CH2SO3H—CO(CH2)4CO—162H2NCH2CHOHCH2OH—NHCH2CHOHCH2OH—CO(CH2)4CO—163CH3NHCH2CO2H—N(CH3)CH2CO2H—CO(CH2)4CO—1642-carboxypyrrole

191

—CO(CO2)4CO—165H2N(CH2CH2O)2H—NH(CH2CH2O)2H—CO(CO2)4CO—1663—N-morpholinoprop- 1-ylamine

192

—CO(CH2)4CO—167HS(CH2)3SO3H—S(CH2)3SO3H—CO(CH2)4CO—

EXAMPLE 168

Preparation of the Compound of Formula (E) wherein R4 is HNCH2CHOHCH2OH and L1 is —COCO—

[0224] The method of Example 160 was repeated except that in place of [(CH2)2CONHNH2]2 there was used an equimolar amount of (oxalyl dihydrazide)2. The resultant chlorotriazine compound (1 part) in water (10 parts) was condensed with H2NCH2CHOHCH2OH (2 parts) at 80° C. for 4 hours to give the compound of Formula (E) wherein R4 is HNCH2CHOHCH2OH and L is —COCO— having λmax at 542 nm.

EXAMPLE 169

Preparation of the Compound of Formula (E) wherein R4 is HNCH2CHOHCH2OH and L1 is —CO(CH2)2CO—

[0225] The method of Example 168 was repeated except that—in place of [(CH2)2CONHNH2]2 there was used on equimolar amount of [(CH2)CONHNH2]2. The resultant compound had a λmax at 545 nm.

Example 170

Preparation of the Compound of Formula (E) wherein R4 is 2-carboxy-N-imidazolyl and L1 is —CO(CH2)2—CO

[0226] The method of Example 160 was repeated except that in place of [(CH2)2CONHNH2]2 there was used an equimolar amount of [(CH2)CONHNH2]2. The resultant chlorotriazine compound (1 part) in water was condensed with 2-carboxy imidazole (2 parts) at 80° C. for 4 hours to give the title compound.

EXAMPLE 171

Preparation of the Compound of the Formula (F) wherein R4 is —CO(CH2)6CH3.

[0227]

193

[0228] 1-Amino-8-hydroxy-3,6-disulpho-2-(2-carboxy phenylazo)naphthalene (prepared as described European Patent application EP682088 A1, page 17, lines 50 to 53) (5 parts) was suspended in water (50 parts) and dissolved by the addition of 2M sodium hydroxide solution to pH7. The solution was cooled to 0-5° C. and a slurry of cyanuric chloride (5.5 part) in water (50 mls) containing calsolene oil (0.1 g). The resulting mixture was stirred for 2 hours at 0-5° C. and the pH of the mixture was maintained at 6.5-7 by the addition of 2M sodium hydroxide solution as required, to give the dichlorotriazinyl compound. Cystine (2.74 parts) was added and the pH of the mixture raised to 8.5 with 2M sodium hydroxide solution. The temperature was allowed to rise to 20-25° C. and the mixture stirred at pH 8.5/20-25° C. for 2.5 hours. Octanoic hydrazide (15 parts) was added and the pH was raised to 10.5-11.0 with 2M sodium hydroxide solution. The mixture was heated to 80-85° C. and held there until the reaction was complete. Sodium chloride was added to 10% w/v and the pH brought to 7 with concentrated hydrochloric acid. The mixture was cooled to 60° C., the product was filtered off and washed with 15% w/v sodium chloride solution. The wet product was dissolved in dilute sodium hydroxide solution and dialysed in visking tubing to low conductivity. The dialysed solution was screened through a 0.71 μm filter and the solution evaporated to dryness at 50° C. to give the title compound having a λmax at 549 nm.

EXAMPLE 172

Preparation of the Compound of Formula (F) wherein R4 is —COCH3

[0229] The method of Example 171 was repeated except that in place of octanoic hydrazide there was used an equimolar amount of ethanoic hydrazide.

[0230] The resultant compound had a λmax at 545 nm.

EXAMPLE 173

Preparation of the Compound of the Formula (G) wherein T is C6H5 and L1 is —CH(CO2H)(CH2)3—

[0231]

194

[0232] The method of Example 171 was repeated except that in place of cystine there was used ornithine and in place of octanoic hydrazide there was used benzoyl hydrazide.

[0233] The resultant compound had a λmax at 549 nm.

EXAMPLE 174

Preparation of the Compound of Formula (G) wherein T is C6H5 and L1 is —CH2CHOHCH2—

[0234] The method of Example 173 was repeated except that in place of ornithine there was used an equimolar amount of 1,3,-diamino-2-hydroxy propane.

EXAMPLE 175

Preparation of the Compound of Formula (G) wherein T is CH3 and L1 is —CH2CHOHCH2—

[0235] The method of Example 173 was repeated except that in place of ornithine there was used an equimolar amount of 1,3-diamino-2-hydroxy propane and in place of benzoyl hydrazide there was used an equimolar amount of ethanoyl hydrazide.

[0236] The resultant compound had a λmax at 551 nm.

EXAMPLE 176

Preparation of the Compound of Formula (G) wherein T is 4-t-butyl phenyl and L1 is —(CH2)2—N(CH2CH2)2N—(CH2)2—

[0237] The method of Example 173 was repeated except that in place of ornithine there was used an equimolar amount of diethylene triamine and in place of benzoyl hydrazide there was used an equimolar amount of tert-butylbenzoic hydrazide.

[0238] The resultant compound had a λmax at 553 nm.

EXAMPLE 177

[0239] The compound from Example 143 and Comparative Dye (X) were made up into an ink according to the general formulation described in Example 142 above.

[0240] The inks were placed in a Canon 4300 ink jet printer and printed onto the papers indicated in Table 12 below. After drying, the light-fastness of the prints were measured by the general method described in Example 142 above and the results are shown in Table 12 below:

14TABLE 12DyePaperΔECompound of Example 143Canon GP 2016Comparative Dye (X)Canon GP 20133

[0241] Table 12 shows that Compound from Example 143 has higher light-fastness (lower ΔE) than Comparative Dye (X).

EXAMPLE 178

Preparation of Compound (A3)

[0242]

195

[0243] Compound (A3)

[0244] Compound (A3) was prepared as follows:

[0245] Stage (a):

[0246] 4-methyl-2-sulpho aniline (56 g) was added to water (500 ml) and cooled to 0-5° C. Concentrated HCl (150 ml) was then added followed by 2N NaNO2 (150 ml). The solution was stirred for 1 hour at 0-5° C. and excess NaNO2 was destroyed by addition of sulphamic acid.

[0247] To the above solution was added 1-acetamido-8-napthol-3,6-disulphonic acid (109.83 g) in water (500 ml). The pH was then raised to 7 by addition of a concentrated solution of NaOH and the solution was stirred for 3 hours at 0-5° C. The solution was then adjusted to pH11 by addition of NaOH pellets and was heated to 85° C. for 6 hours.

[0248] The pH was then reduced to 7 by addition of concentrated HCl and the solution was salted to 20% with NaCl. The resulting precipitate was filtered-off, washed and dried.

[0249] Stage (b):

[0250] The product of stage (a) (29.0 g, 0.05 moles) was suspended in water (800 mls) and dissolved by the addition of sodium hydroxide (2M) to pH7. The mixture was then cooled to <5° C. and a slurry of cyanuric chloride (10.2 g, 0.055 moles) in water (50 mls) and calsolene oil (0.1 g) was added. The resultant mixture was stirred at below 5° C. for 2 hours maintaining the pH of the mixture at between pH 6.5 and 7.0 by the addition of sodium hydroxide solution (2M) as required.

[0251] Stage (c):

[0252] Pterepthaloyl hydrazide (from Aldrich) (4.8 g (0.0275 moles)) was added to the product of stage (a) and the pH of the mixture raised to pH 8.5 using sodium hydroxide solution (2M). The temperature of the reaction mixture was allowed to rise to 20-25° C. and then the mixture was stirred at pH 8.5 at 20-25° C. for 2.5 hours.

[0253] 1.4-diazabicyclo[2,2,2]octane was added and the pH of the mixture was raised to pH 10.5-11.0 with sodium hydroxide solution (2M). The mixture was then heated to 80-85° C. and maintained at the temperature until the hydrolysis reaction was complete.

[0254] Sodium chloride solution was then added 1% to 10% w/v and the pH of the mixture lowered to pH 7 using concentrated hydrochloric acid.

[0255] The mixture was then cooled to 60° C. and the product filtered and washed with 15% w/v sodium chloride solution.

[0256] The resultant wet product was subsequently dissolved in dilute sodium hydroxide solution and dialysed in visking tubing to low conductivity.

[0257] The dialysed solution was screened through a 0.7 μm filter and the solution evaporated to dryness at 50° C. to give Compound (A3) having a λmax at 551 nm.

EXAMPLE 179

[0258] Compound (B2)

196

[0259] Compound (B2) was prepared by the method described in Example 178 except that in place of 4-methyl-2-sulphoaniline there was used 2-carboxyaniline and in place of pterephthaloyl hydrazide there was used isophthaloyl hydrazide.

EXAMPLE 180

[0260] Compound (C1)

197

[0261] Compound (C1) was prepared by the method described in Example 178 except that in place of 4-methyl-2-sulphoaniline there was used 2-carboxy aniline.

EXAMPLE 181

[0262] Compound (D1)

198

[0263] Compound (D1) was prepared according to the method of Example 178 except that in place of pterephthaloyl hydrazide there was used isophthaloyl hydrazide.

EXAMPLE 182

[0264] Compound (E1)

199

[0265] Compound (E1) was prepared according to the method of Example 178 except that in place of 4-methyl-2-sulphoaniline there was used 4-methyl-2-carboxyaniline to give Compound (E1) having a λmax at 550 nm.

EXAMPLE 183

[0266] Compounds (B2) and (C1) from Examples 179 and 180 and Comparative Dye (X) respectively were made up into an ink according to the general formulation described in Example 142 above.

[0267] The inks were placed in a Canon 4300 ink jet printer and printed onto the papers indicated in Table 13 below. After drying, the light-fastness of the prints were measured by the general method described in Example 142 above and the results are shown in is Table 13 below:

15TABLE 13CompoundPaperΔECompound (B2)Canon HG 20112Compound (C1)Canon HG 20112Comparative Dye (X)Canon HG 20124Compound (B2)Canon GP 30118Compound (C1)Canon GP 30118Comparative Dye (X)Canon GP 30151

[0268] Table 13 shows that Compounds (B2) and (C1) have higher light-fastness (lower ΔE) than Comparative Dye (X).

EXAMPLE 184

[0269] The inks described in Tables 14 to 22 may be prepared wherein the compound described in the first column is the compound described in the above examples. Numbers quoted in the second column onwards refer to the number of parts of the s relevant ingredient and all parts are by weight. The inks may be applied to paper by thermal or piezo ink jet printing.

[0270] The following abbreviations are used in Table I and II:

[0271] PG=propylene glycol

[0272] DEG=diethylene glycol

[0273] NMP=N-methyl pyrollidone

[0274] DMK=dimethylketone

[0275] IPA=isopropanol

[0276] MEOH=methanol

[0277] 2P=2-pyrollidone

[0278] MIBK=methylisobutyl ketone

[0279] P12=propane-1,2-diol

[0280] BDL=butane-2,3-diol

[0281] CET=cetyl ammonium bromide

[0282] PHO=Na2HPO4 and

[0283] TBT=tertiary butanol

[0284] TDG=thiodiglycol

[0285] Proxel XL-2=biocide from Avecia Inc.

[0286] SUR=Surfynol 465 (an acetylinic surfactant)

[0287] GLY=glycerin

[0288] DGM=diethylene glycol monobutyl ether

[0289] SUR2=Surfynol 485

[0290] TEG=triethylene glycol monobutyl ether

[0291] (further ink formulations may be prepared using the compositions described in U.S. Pat. No. 5,749,951 except that in place of the colorants used therein there is used an equal weight of the compound of Example 144).

16TABLE 14ComponentNaComponentContentWaterPGDEGNMPDMKNaOHStearateIPAMEOH2PMIBK12.080564523.090550.2310.0853335142.1918113.18650.24521.18190.50.5932.56041533610544565201042.4755456534.180352100.323.265546546515.1964110.89055210.08026251431.88051542.68411543.38021026312.09070.3325.469220213316.09145

[0292]

17

TABLE 15

Dye

Dye
Content
Water
PG
DEG
NMP
CET
TBT
TDG
BDL
PHO
2P
PI2

4
3.0
80
15

0.2

5

3
9.0
90

5

1.2

5

2
1.5
85
5
5

0.15
5.0
0.2

1
2.5
90

6
4

0.12

1
3.1
82
4
8

0.3

6

2
0.9
85

10

5
0.2

3
8.0
90

5
5

0.3

4
4.0
70

10
4

1

4
11

4
2.2
75
4
10
3

2

6

3
10.0
91

6

3

2
9.0
76

9
7

3.0

0.95
5

1
5.0
78
5
11

6

4
5.4
86

7

7

3
2.1
70
5
5
5
0.1
0.2
0.1
5
0.1
5

2
2.0
90

10

1
2
88

10

2
5
78

5

12

5

3
8
70
2

8

15

5

4
10
80

8

12

4
10
80

10

[0293]

18

TABLE 16

Compound

Na

Compound
Content
Water
PG
DEG
NMP
DMK
NaOH
Stearate
IPA
MEOH
2P
MIBK

7
2.0
80
5

6
4

5

8
3.0
90

5
5

0.2

9
10.0
85
3

3
3

5
1

11
2.1
91

8

1

13
3.1
86
5

0.2
4

5

15
1.1
81

9

0.5
0.5

9

17
2.5
60
4
15
3
3

6
10
5
4

19
5
65

20

10

26
2.4
75
5
4

5

6

5

36
4.1
80
3
5
2
10

0.3

46
3.2
65

5
4
6

5
4
6
5

55
5.1
96

4

58
10.8
90
5

5

74
10.0
80
2
6
2
5

1

4

81
1.8
80

5

15

51
2.6
84

11

5

116
3.3
80
2

10

2

6

126
12.0
90

7
0.3

3

156
5.4
69
2
20
2
1

3
3

131
6.0
91

4

5

[0294]

19

TABLE 17

Compound

Compound
Content
Water
PG
DEG
NMP
CET
TBT
TDG
BDL
PHO
2P
PI2

141
3.0
80
15

0.2

5

98
9.0
90

5

1.2

5

92
1.5
85
5
5

0.15
5.0
0.2

57
2.5
90

6
4

0.12

117
3.1
82
4
8

0.3

6

135
0.9
85

10

5
0.2

113
8.0
90

5
5

0.3

69
4.0
70

10
4

1

4
11

21
2.2
75
4
10
3

2

6

30
10.0
91

6

3

25
9.0
76

9
7

3.0

0.95
5

47
5.0
78
5
11

6

77
5.4
86

7

7

97
2.1
70
5
5
5
0.1
0.2
0.1
5
0.1
5

87
2.0
90

10

107
2
88

10

113
5
78

5

12

5

121
8
70
2

8

15

5

32
10
80

8

12

45
10
80

10

[0295]

20

TABLE 18

Compound

Na

Compound
Content
Water
PG
DEG
NMP
DMK
NaOH
Stearate
IPA
MEOH
2P
MIBK

138
2.0
80
5

6
4

5

139
3.0
90

5
5

0.2

140
10.0
85
3

3
3

5
1

141
2.1
91

8

1

142
3.1
86
5

0.2
4

5

143
1.1
81

9

0.5
0.5

9

144
2.5
60
4
15
3
3

6
10
5
4

139
5
65

20

10

146
2.4
75
5
4

5

6

5

147
4.1
80
3
5
2
10

0.3

148
3.2
65

5
4
6

5
4
6
5

149
5.1
96

4

150
10.8
90
5

5

151
10.0
80
2
6
2
5

1

4

152
1.8
80

5

15

153
2.6
84

11

5

139
3.3
80
2

10

2

6

155
12.0
90

7
0.3

3

156
5.4
69
2
20
2
1

3
3

157
6.0
91

4

5

[0296]

21

TABLE 19

Compound

Compound
Content
Water
PG
DEG
NMP
CET
TBT
TDG
BDL
PHO
2P
PI2

158
3.0
80
15

0.2

5

159
9.0
90

5

1.2

5

139
1.5
85
5
5

0.15
5.0
0.2

161
2.5
90

6
4

0.12

162
3.1
82
4
8

0.3

6

163
0.9
85

10

5
0.2

164
8.0
90

5
5

0.3

139
4.0
70

10
4

1

4
11

166
2.2
75
4
10
3

2

6

167
10.0
91

6

3

168
9.0
76

9
7

3.0

0.95
5

169
5.0
78
5
11

6

170
5.4
86

7

7

171
2.1
70
5
5
5
0.1
0.2
0.1
5
0.1
5

138
2
88

10

139
5
78

5

12

5

150
8
70
2

8

15

5

139
10
80

8

12

155
10
80

10

[0297]

22

TABLE 20

Compound

Proxel

Compound
Content
Water
DGM
TEG
NMP
GLY
NaOH
SUR
SUR2
DEG
2P
XL-2

138
2.0
80
10

1
4

5

139
3.0
90

10

0.2

139
10.0
81
10
5
3

1

141
2.1
84
5
10

0.7

0.3

139
3.1
86
5

8.4

0.2
0.2

0.2

143
1.1
81

9

6

1.2

2.8

140
2.5
70
4
5
3
3

0.1
10
4.9

139
5
65

20

14.4

0.6

139
2.4
75
5
4

5

6
4.75
0.25

147
4.1
80
3
5
2
9.7

0.3

139
3.2
65

17.7

6

1.0
4
6
0.3

149
5.1
96

4

150
2.6
90
5

4.2

0.8

139
3.2
80
2
6
2
5

1.0

4

152
1.8
80

5

15

139
2.6
84

11

5

139
3.3
80
10

9

0.3
0.4

0.3

151
2.1
90
1
1

7
0.3

0.7

139
5.4
69
2
20
2
2
1
0.7
0.4

3
0.3

157
6.0
91
1
1
1
1

1
1
1
1
1

[0298]

23

TABLE 21

Compound

Na

Compound
Content
Water
PG
DEG
NMP
DMK
NaOH
Stearate
IPA
MEOH
2P
MIBK

A3
2.0
80
5

6
4

5

B2
3.0
90

5
5

0.2

C1
10.0
85
3

3
3

5
1

D1
2.1
91

8

1

E1
3.1
86
5

0.2
4

5

A3
1.1
81

9

0.5
0.5

9

C1
2.5
60
4
15
3
3

6
10
5
4

E1
5
65

20

10

B2
2.4
75
5
4

5

6

5

D1
4.1
80
3
5
2
10

0.3

B2
3.2
65

5
4
6

5
4
6
5

D1
5.1
96

4

A3
10.8
90
5

5

C1
10.0
80
2
6
2
5

1

4

E1
1.8
80

5

15

E1
2.6
84

11

5

D1
3.3
80
2

10

2

6

C1
12.0
90

7
0.3

3

B2
5.4
69
2
20
2
1

3
3

A3
6.0
91

4

5

[0299]

24

TABLE 22

Compound

Compound
Content
Water
PG
DEG
NMP
CET
TBT
TDG
BDL
PHO
2P
PI2

A3
3.0
80
15

0.2

5

B2
9.0
90

5

1.2

5

C1
1.5
85
5
5

0.15
5.0
0.2

D1
2.5
90

6
4

0.12

E1
3.1
82
4
8

0.3

6

A3
0.9
85

10

5
0.2

C1
8.0
90

5
5

0.3

E1
4.0
70

10
4

1

4
11

B2
2.2
75
4
10
3

2

6

D1
10.0
91

6

3

B2
9.0
76

9
7

3.0

0.95
5

D1
5.0
78
5
11

6

A3
5.4
86

7

7

C1
2.1
70
5
5
5
0.1
0.2
0.1
5
0.1
5

E1
2.0
90

10

B2
2
88

10

A3
5
78

5

12

5

B2
8
70
2

8

15

5

B2
10
80

8

12

B2
10
80

10

Number	Date	Country
0105321.4	Mar 2001	GB
0105324.8	Mar 2001	GB
0105325.5	Mar 2001	GB
0105328.9	Mar 2001	GB
0106007.8	Mar 2001	GB

Ink jet printing composition comprising a dye containing hydrazine or hydrazide

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Priority Claims (5)

PCT Information